GCM
AZN icon

Gunderson Capital Management’s AstraZeneca AZN Stock Holding History

Gunderson Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-39,302
Closed -$4.3M – 50
2020
Q3 		$4.3M Buy
39,302
+937
+2% +$104K 3.72% 16
2020
Q2 		$4.06M Buy
38,365
+34,405
+869% +$3.55M 3.27% 18
2020
Q1 		$354K Sell
3,960
-956
-19% -$90K 0.49% 32
2019
Q4 		$490K Buy
+4,916
New +$463K 0.54% 34

Other funds holding AZN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gunderson Capital Management's AZN Position: Q4 2020 in Review

Gunderson Capital Management sold out of AstraZeneca (AZN) in Q4 2020, closing a stake of 39,302 shares — an estimated $4.3M sold.

Gunderson Capital Management first reported a position in AZN in Q4 2019 and held it in 4 quarters. The position peaked at $4.3M in Q3 2020. 786 funds tracked by Wall St. Rank hold AZN as of Q4 2020.

  • Gunderson Capital Management reported no remaining AstraZeneca position as of Q4 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 39,302 AstraZeneca shares in Q4 2020, an estimated $4.3M.
  • Gunderson Capital Management first reported a position in AstraZeneca in Q4 2019 and held it in 4 quarters.
  • Gunderson Capital Management's AstraZeneca position peaked at $4.3M in Q3 2020.
  • 786 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2020.

Based on Gunderson Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.